D. Ross Camidge - Oncol, Univ Colorado Hosp

基本信息

浏览量：227

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 48 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Real-world Outcomes in Patients with EGFR Wildtype Non-squamous Locally Advanced/Metastatic NSCLC Receiving Second- or Third-Line Docetaxel: Pooled Analysis from LUMINATE-101

Nicolas Girard, Qingqing Xu,D. Ross Camidge,Shobhit Baijal,Sudeep Karve, Sophia Ng,Rajesh Kamalakar,Christine Ratajczak, Allison Allen, Shun Luc

JOURNAL OF THORACIC ONCOLOGYno. 7 (2024): E28-E29

引用0浏览0引用

Phase 2 Trial of Mecbotamab Vedotin (BA3011), a CAB-AXL-ADC, Alone or in Combination with Nivolumab in Patients with Non-Squa

Julia Rotow, Grace K. Dy,D. Ross Camidge

JOURNAL OF THORACIC ONCOLOGYno. 7 (2024): E7-E7

引用0浏览0引用

First-in-human Clinical Outcomes with NG-350A, an Anti-Cd40 Expressing Tumor-Selective Vector Designed to Remodel Immunosuppressive Tumor Microenvironments

Aung Naing,Danny Khalil, Oliver Rosen,D Ross Camidge,Tom Lillie, Rui-Ru Ji, Andrea Stacey, Matthew Thomas,Lee Rosen

Journal for immunotherapy of cancerno. 10 (2024)

引用0浏览0WOS引用

EP08.02-019 Phase 1/2 Study of BLU-701, a Highly Selective EGFR Inhibitor, in Patients with EGFR-Mutant Non-Small Cell Lung Cancer

A. Spira,D.R. Spigel,R. Camidge,A.J. de Langen,T.M. Kim, K. Goto,Y. Elamin,E. Shum,K.L. Reckamp,J. Rotow, S. Goldberg,S. Gadgeel,T.A. Leal,F. Albayya, S. Fitzpatrick,M. Louie-Gao,J. Parepally,A. Zalutskaya, H. Yu

Journal of Thoracic Oncologyno. 9 (2022)

引用0浏览0引用

EP08.02-029 Sunvozertinib in NSCLC Patients with EGFR Exon20 Insertion Mutations: Effect of Prior Treatment

J.C.-H. Yang, M. Wang,P. Mitchell, J. Fang,W. Nian,C-h. Chiu, J. Zhou, Y. Zhao,W.-C. Su,R. Camidge,T.-Y. Yang,V. Zhu,M. Millward, Y. Fan,W.-T. Huang, Y. Cheng, L. Jiang,D. Brungs, L.B. Bazhenova, C.K. Lee

Journal of thoracic oncologyno. 9 (2022): S410-S411

引用1浏览0引用

Phase 1/2 Study of BLU-701, a Highly Selective EGFR Inhibitor, in Patients With EGFR-Mutant Non-Small Cell Lung Cancer

A. Spira,D. R. Spigel,R. Camidge,A. J. De langen,T. M. Kim, K. Goto,Y. Elamin,E. Shum,K. L. Reckamp,J. Rotow, S. Goldberg,S. Gadgeel,T. A. Leal,F. Albayya, S. Fitzpatrick,M. Louie-Gao,J. Parepally,A. Zalutskaya,H. Yu

JOURNAL OF THORACIC ONCOLOGY（2022）

引用0浏览0引用

Sunvozertinib in NSCLC Patients with EGFR Exon20 Insertion Mutations: Effect of Prior Treatment

J. C. -H. Yang, M. Wang,P. Mitchell, J. Fang,W. Nian,C-H. Chiu, J. Zhou, Y. Zhao,W. -C. Su,R. Camidge,T. -Y. Yang,V. Zhu,M. Millward, Y. Fan,W. -T. Huang, Y. Cheng, L. Jiang,D. Brungs, L. B. Bazhenova, C. K. Lee, B. Gao, L. Zheng,P. Janne

JOURNAL OF THORACIC ONCOLOGY（2022）

引用1浏览0引用

Time To First Progression In Patients With Nsclc With Brain Metastases Receiving 3rd Generation Tki Alone Vs Tki Plus Brain Radiation

N. Thomas,N. Myall,F. Sun,T. Patil,R. Mushtaq,C. Yu,E. Pollom,S. Nagpal,R. Camidge,C. Rusthoven,S. Braunstein,H. A. Wakelee,C. Mccoach

JOURNAL OF THORACIC ONCOLOGY（2021）

引用2浏览0引用

P84.11 Real-World Brigatinib Dosing Patterns in Patients with Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer in the United States

H. Lin,Y. Wu,M. Gorritz,C. Mcguiness,W. Huang,C. Chen,K. Ren,R. Camidge

Journal of thoracic oncology（2021）

引用0浏览0引用

P09.53 Comparative Effectiveness of Crizotinib versus Entrectinib in ROS1+ Non-Small Cell Lung Cancer (NSCLC) using Clinical Trial and Real-World Data

M. Groff,G. Tremblay,L. Iadeluca,K. Wilner,R. Wiltshire,L. Bartolome,T. Usari,J. Cappelleri,R. Camidge

Journal of Thoracic Oncology（2021）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn